A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Ketamine
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Ticagrelor.
Ketamine
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Ticagrelor.
Ketamine
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Ticagrelor.
Ketamine
Eliglustat
The metabolism of Eliglustat can be decreased when combined with Ticagrelor.
Ketamine
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Ticagrelor.
Ketamine
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Ticagrelor.
Ketamine
Brentuximab vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Ticagrelor.
Ketamine
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Ticagrelor.
Ketamine
Obinutuzumab
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Obinutuzumab.
Ketamine
Glucosamine
Glucosamine may increase the antiplatelet activities of Ticagrelor.
Ketamine
Hyodeoxycholic Acid
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Hyodeoxycholic Acid.
Ketamine
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Dehydrocholic acid.
Ketamine
Bamet-UD2
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Bamet-UD2.
Ketamine
Tauroursodeoxycholic acid
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Tauroursodeoxycholic acid.
Ketamine
Taurochenodeoxycholic acid
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Taurochenodeoxycholic acid.
Ketamine
Chenodeoxycholic acid
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Chenodeoxycholic acid.
Ketamine
Vorapaxar
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ticagrelor.
Ketamine
Tibolone
Tibolone may increase the anticoagulant activities of Ticagrelor.
Ketamine
Sugammadex
The risk or severity of bleeding and hemorrhage can be increased when Ticagrelor is combined with Sugammadex.
Ketamine
Edoxaban
The risk or severity of bleeding can be increased when Edoxaban is combined with Ticagrelor.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3